Oxford COVID Vaccine

DGCI Gave Approvals To Serum Institute for Clinical Trials of Oxford COVID-19 Vaccine

The DCGI, however, put certain conditions like taking extra care during screening, providing additional information in informed consent and close monitoring for adverse events during follow-up of the study which have to be "scrupulously" followed by Serum Institute of India (SII).